Related Experiment Video
Updated: Jul 3, 2026
Rapid In Vitro Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging
Published on: October 27, 2023
[Effects of beta-catenin-specific siRNA interference on Jurkat and K562 cells]
Yu-Jie Mai1, Lu-Gui Qiu, Zeng-Jun Li
1State Key Laboratory of Hematology, Institute of Hematology, Blood Disease Hospital, CAMS and PUMC, Tianjin 300020, China.
Objective:
To inhibit the expression of beta-catenin and investigate the effect of the beta-catenin gene on Jurkat and K562 cells.
Methods:
siRNA specifically knocking down the expression of beta-catenin was used to testify the function of beta-catenin in Jurkat and K562 cells. Real time polymerase chain reaction and Western blot were performed respectively to testify the mRNA level and protein level of beta-catenin. Growth curve was determined by counting viable cells using trypan blue refusal-dyed method. The proliferation of cells was assayed by clonogenic counting and MTT method. The apoptotic cells were measured by Annexin V/PI staining. The cell cycle analysis was performed based on propidium iodide staining.
Results:
Compared with the control group (transfected with siRNA directed against scramble gene), the survival, colonogenicity, and proliferation of the Jurkat and K562 cells were significantly decreased in experimental group transfected with beta-catenin siRNA. The colonogenicity was decreased from 31.9 +/- 5.55 (siRNA) to 25.0 +/- 5.13 (control) in Jurkat cells, and from 47.33 +/- 8.52 (siRNA) to 39.33 +/- 6.26 (control) in K562 cells (both P <0.05). The inhibition rate was (49.3 +/- 9.86)% (siRNA) and (15.1 +/- 6.55)% (control) respectively in Jurkat cells, and (39.4 +/- 7.56)% (siRNA) and (10.1 +/- 6.89)% (control) in K562 cells (both P <0.05). In addition, the apoptotic rate increased from (23.5 +/- 2.82)% (control group) to (55.9 +/- 2.22)% (experiment group) in Jurkat cells and from (14.9 +/- 8.54)% (control group) to (27.9 +/- 15.3)% (experiment group) in K562 cells. However, cell cycle analysis revealed no obvious phases change both in Jurkat and in K562 cells.
Conclusion:
Knock-down of beta-catenin gene may decrease the proliferation, survival, and clonogenicity in Jurkat cells and K562 cells.
Insights
Knocking down the beta-catenin gene significantly reduced the survival and proliferation of Jurkat and K562 cancer cells. This inhibition of beta-catenin may offer a new therapeutic strategy for these cell types.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Context:
- Beta-catenin plays a crucial role in cell adhesion and signaling pathways.
- Dysregulation of beta-catenin is implicated in various cancers.
- Understanding beta-catenin's function in cancer cells is vital for developing targeted therapies.
Purpose:
- To investigate the functional role of beta-catenin in Jurkat and K562 cancer cells.
- To determine the effects of beta-catenin gene knockdown on cancer cell proliferation, survival, and apoptosis.
Summary:
- Short interfering RNA (siRNA) was used to specifically inhibit beta-catenin expression in Jurkat and K562 cells.
- Real-time PCR and Western blot confirmed successful knockdown at both mRNA and protein levels.
- Knockdown significantly decreased cell survival, proliferation, and clonogenicity while increasing apoptosis.
Impact:
- Beta-catenin gene knockdown demonstrates a significant inhibitory effect on cancer cell growth.
- Targeting beta-catenin could be a potential therapeutic approach for certain hematological malignancies.
- Further research is warranted to explore the clinical applicability of beta-catenin inhibition.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:15Experimental RNAi